Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2010-018624-20Phase 4Completed
Phase 4, open-label trial of Softa-Man, Sterillium Virugard and Manorapid Synergy (4 arms), sponsored by University Hospital Freiburg. Primary endpoint: Transepidermal water loss. Started Apr 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2010-018624-20.